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Transforming growth factor β (TGF-β) induced differentiation of lung fibroblasts to
myofibroblasts is a key event in the pathogenesis of pulmonary fibrosis. This study aimed
to evaluate the effect of curcumin on TGF-β induced differentiation of lung fibroblasts
to myofibroblasts and explore the underlying mechanism. Mouse lung fibroblasts were
cultured and treated with TGF-β2 and curcumin or rosiglitazone. Cell vitality was
examined by MTT assay. The secretion of collagen-1 was assessed by ELISA. α smooth
muscle actin (α-SMA) was visualized by immunofluorescence technique. The expression
of peroxisome proliferator activated receptor γ (PPAR-γ) and platelet derived growth
factor R β (PDGFR-β) was detected by PCR and Western blot analysis. We found that
curcumin and rosiglitazone inhibited the proliferation and TGF-β induced differentiation
of mouse lung fibroblasts. In addition, curcumin and rosiglitazone inhibited collagen-1
secretion and α-SMA expression in mouse lung fibroblasts. Furthermore, curcumin and
rosiglitazone upregulated PPAR-γ and downregulated PDGFR-β expression in mouse
lung fibroblasts. In conclusion, our study reveals novel mechanism by which curcumin
inhibits TGF-β2 driven differentiation of lung fibroblasts to myofibroblasts. Curcumin
could potentially be used for effective treatment of pulmonary fibrosis.
Keywords: curcumin, peroxisome proliferator activated receptor γ, platelet derived growth factor receptor β,
pulmonary fibrosis, transforming growth factor β2
INTRODUCTION
Idiopathic pulmonary fibrosis (IPF) is a progressive disease of unknown etiology that can
result in respiratory failure (Meltzer and Noble, 2008; Wilson and Wynn, 2009). The principle
manifestations of IPF include mild inflammation, fibroblast foci, and extensive extracellular
matrix (ECM) deposition in the lung tissue (Pardo and Selman, 2012; Sakai and Tager, 2013).
Fibroblasts are major effector cells in the development of pulmonary fibrosis due to their ability
to differentiate into myofibroblasts and produce excess ECM components, including collagen and
fibronectin (Nathan et al., 2011; Olson and Swigris, 2012; Chełstowska et al., 2014). Myofibroblasts
are characterized by the expression of alpha smooth muscle actin (α-SMA), calponin and ECM
proteins including Type I and III collagen (Col1A1 and Col3A1), fibronectin and proteoglycan
(Nathan et al., 2011).
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Transforming growth factor β (TGF-β) is a pleiotropic
cytokine that promotes the differentiation of fibroblasts to
myofibroblasts and plays a major role in fibrosis. Binding
of active TGF-β to its receptor triggers several signaling
pathways including Smad pathway and phosphotidylinositol-3-
kinase (PI3K)/Akt/Protein Kinase B (PKB) pathway (Guo and
Wang, 2008; Assinder et al., 2009; Santibanez et al., 2011). In fetal
lung fibroblasts, TGF-β activates Akt signaling via p38 Mitogen
Activated Protein Kinase (MAPK) and Focal Adhesion Kinase
(FAK; Kulkarni et al., 2011).
Curcumin is derived from the rhizomes of the curcuma
longa plant commonly known as turmeric, and has long
been used as a medicinal agent in many Asian countries
(Maheshwari et al., 2006). Curcumin has shown a variety of
potentially beneficial effects, including lower blood pressure,
anti-tumor, anti-inflammatory, choleretic, antioxidant, and anti-
inflammatory activities (Nakagawa et al., 2014; Seo et al., 2014;
Zhang Y. et al., 2014). Notably, curcumin effectively reduces
profibrotic effects in fibroblasts in vitro via the inhibition of key
steps in the TGF-β signaling pathway (Smith et al., 2010). It was
reported that the activation of peroxisome proliferator-activated
receptor gamma (PPAR-γ) by curcumin blocked platelet derived
growth factor (PDGF) signaling pathway in hepatic stellate cells
(Lin and Chen, 2008). However, the relationship of PPAR-
γ and PDGF signaling pathway is unclear in TGF-β induced
differentiation of lung fibroblasts to myofibroblasts.
Here, we report that curcumin exhibited anti-fibrosis effect
by inhibiting TGF-β induced differentiation of mouse lung
fibroblasts to myofibroblasts and this may be mediated by the
regulation of PPAR-γ and PDGFR.
MATERIALS AND METHODS
Cell Culture and Treatment
Mouse lung fibroblast cell line was purchased from American
Type Culture Collection (Cat. # CRL-6013TM) and maintained
in dulbecco’s modified eagle medium (DMEM, Hyclone, USA)
supplemented with 10% fetal bovine serum (FBS), 100 U/ml
penicillin and 100 µg/ml streptomycin at 37◦C in a humidified
atmosphere with 5% CO2. After the cells reached 70–80%
confluence, the cells were digested with 0.25% trypsin to passage,
and the medium was changed every other day. Cells were
used between passages 5–9. PPAR-γ ligand rosiglitazone (Sigma-
Aldrich, USA) was dissolved in DMSO and added to cultured
cells to the final concentrations of 5, 10, 20, and 40 µM as
described previously (Hogan et al., 2011). Curcumin (Sigma-
Aldrich, USA) was prepared in the same manner and added to
cultured cells to the final concentrations of 5, 25, and 50 µM as
described previously (Hwang et al., 2013). Recombinant mouse
TGF-β2 (R&D Systems, USA) was used at a final concentration
of 10 ng/ml as described previously (Ma et al., 2014).
RT-PCR
Total RNA was extracted from mouse lung fibroblasts with Trizol
(Invitrogen, USA) following the manufacturer’s instructions and
stored at −80◦C. The cDNA was synthesized from 2 µl of total
RNA and used for PCR using PrimeScript RT-PCR Kit (TaKaRa,
Japan). The primer sequences were as follows: PPAR-γ Forward
5′-GCCCTTTACCACAGTTGATTTC-3′ Reverse 5′-GATGCTT
TATCCCCACAGACTC-3′; FGF-R1 Forward 5′-GGAGGAGA
GAGTGAGAGGATGA-3′ Reverse 5′-TGAGTGGTGTGGGTT
TGAATAA-3′; PDGFR-β Forward 5′-GTGGTCCTTACCGT
CATCTCTC-3′ Reverse 5′-CTTCTCGCTACTTCTGGCTGTC-
3′; β-actin Forward 5′-ATATCGCTGCGCTGGTCGTC-3′
Reverse 5′-AGGATGGCGTGAGGGAGAGC-3′. The parameters
for PCR were denaturation at 94◦C for 3 min; 30 cycles of
denaturation at 94◦C for 30 s, annealing at 52◦C for 30 s,
extension at 72◦C for 1 min; final extension at 72◦C for 10 min.
Aliquots of PCR amplification products were electrophoresed on
2% agarose gels containing ethidium bromide and analyzed by
Bio-Rad ChemiDoc image acquisition system and Quantity One
(v4.6) software (Bio-Rad, Hercules, CA, USA).
Western Blot Analysis
Mouse lung fibroblasts were suspended in ice-cold RIPA
and lysed in lysis buffer for 30 min. The lysates were
centrifuged at 14,000 rpm for 15 min and the supernatants
were stored at −80◦C. Protein concentrations were determined
using the Bradford assay (Pierce, USA). Samples containing
40 µg total protein were separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE), then transferred to polyvinylidene
difluoride membranes (PVDF, Roche) and immunoblotted with
anti-PPAR-γ (1:1,000) or anti-β-actin (1:2,000) antibody. The
membranes were then incubated with appropriate secondary
antibody coupled to horseradish peroxidase and visualized by
enhanced chemiluminescence (ECL) detection. β-actin was used
as loading control. Densitometric analysis of the bands was
performed using Quantity One software.
Indirect Immunofluorescence Assay
Cells were seeded in 4-well chamber slides and cultured
overnight, then treated with rosiglitazone (40 µM) or curcumin
(50 µM) for 1 h followed by TGF-β2 (10 ng/ml) treatment for
24 h. Cells were washed, fixed with chilled methanol (−20◦C)
for 15 min, then washed again and air dried. After equilibration
in a humidified chamber, the cells were blocked in 1% BSA in
PBS for 30 min, and then stained with anti-α-SMA (Abcam,
UK) and anti-mouse AlexaFluor 488 (Invitrogen, USA). Slides
were mounted with Prolong Gold supplemented with DAPI
(Invitrogen, USA) to visualize the nuclei and analyzed by
fluorescence-microscopy using a Leica Microscope.
MTT Assay
Cells were seeded in 96-well plates and cultured overnight. Next
the cells were treated with rosiglitazone (40 µM) or curcumin
(50 µM) for 1 h followed by TGF-β2 (10 ng/ml) treatment
for 24 h. Viable cells were evaluated with MTT assay kit
(Sigma, USA) according to the manufacturer’s instructions. The
absorption value was read at 490 nm using a microplate reader.
ELISA Assay
The supernatants of cell culture were collected and the
concentration of collagen I in the supernatants was determined
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by using Mouse Collagen Type I ELISA Kit (MyBioSource Inc,
San Diego, CA, USA) following the manufacturer’s instructions.
Statistical Analysis
Data were expressed as mean ± SEM. Statistical analysis was
carried out with one-way ANOVA using SPSS 17.0 (SPSS Inc,
Chicago, IL, USA). Statistical significance was set at P < 0.05.
RESULTS
Curcumin Inhibits TGF-β2 Induced
Proliferation of Mouse Lung Fibroblasts
Fibroblast proliferation plays a key role in the development
of IPF. First, we assessed potential anti-proliferative effects
of curcumin and rosiglitazone on fibroblasts. Mouse lung
fibroblasts were treated with curcumin or rosiglitazone at
various concentrations. The results showed that curcumin and
rosiglitazone inhibited the proliferation of mouse lung fibroblasts
in a dose and time dependent manner (Figure 1). The inhibition
was significant both in the absence and in the presence of TGF-β2
(10 ng/ml).
Curcumin Potently Inhibits TGF-β2
Induced Secretion of Collagen I
TGF-β is known to increase collagen secretion by fibroblasts
and promote their differentiation to myofibroblasts (Piersma
et al., 2015). Next, we examined the effects of curcumin and
rosiglitazone on TGF-β2 induced myofibroblast differentiation.
Under microscope we found that TGF-β2 stimulated
morphological change of mouse lung fibroblasts, but this
could be partially reversed after treatment with curcumin or
rosiglitazone (Figure 2). Furthermore, ELISA showed that
TGF-β2 stimulated the secretion of collagen I, but this could
be significantly inhibited by curcumin and rosiglitazone.
In particular, curcumin was more effective at inhibiting
collagen I secretion than Rosiglitazone (Figure 3). These data
suggest that curcumin inhibits TGF-β2 induced myofibroblast
differentiation.
Curcumin Inhibits TGF-β2 Induced
Myofibroblast Differentiation
Expression of α-SMA is a key indicator of myofibroblast
differentiation. To confirm that curcumin inhibits TGF-β2
induced myofibroblast differentiation, we performed
immunocytochemical analysis of α-SMA expression in lung
fibroblasts treated with curcumin (50 µM) or rosiglitazone
(40 µM) in the presence of TGF-β2 (10 ng/ml). TGF-β2
treatment resulted in enhanced expression of α-SMA that
was inhibited by curcumin and rosiglitazone. In particular,
curcumin was more effective at inhibiting α-SMA expression
than Rosiglitazone (Figure 4). These data demonstrate
that curcumin inhibits TGF-β2 induced myofibroblast
differentiation.
FIGURE 1 | Curcumin inhibits transforming growth factor β (TGF-β2) induced proliferation of mouse lung fibroblasts. Mouse lung fibroblasts were treated
with various concentrations of curcumin and rosiglitazone in the absence or presence of TGF-β2. Cell proliferation was assessed at 0, 24, 48, and 72 h. Data were
presented as mean ± SEM. Cur, curcumin; Rosi, rosiglitazone.
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FIGURE 2 | Curcumin inhibits TGF-β2 induced morphological changes
of mouse lung fibroblasts. Mouse lung fibroblasts were treated with vehicle,
TGF-β2, or TGF-β2 together with curcumin or rosiglitazone. Cell morphology
was assessed at 0, 24, 48, and 72 h. Cur, curcumin; Rosi, rosiglitazone.
FIGURE 3 | Curcumin potently inhibits TGF-β2 induced secretion of
collagen I. Mouse lung fibroblasts were treated with 10 ng/ml TGF-β2 alone
or after pretreatment with 50 µM curcumin or 40 µM rosiglitazone, and the
secretion of collagen I was determined by ELISA. #Significant increase after
TGF-β2 treatment compared with control (P < 0.05, ANOVA).∗Significant
reduction after curcumin or rosiglitazone treatment compared with TGF-β2
alone (P < 0.05, ANOVA). Cur, curcumin; Rosi, rosiglitazone.
Curcumin Upregulates PPAR-γ while
Downregulates PDGFR-β during TGF-β2
Induced Myofibroblast Differentiation
Finally, we explored the mechanism by which curcumin inhibits
TGF-β2 induced myofibroblast differentiation. Lung fibroblasts
were treated with TGF-β2 alone or in combination with different
concentrations of curcumin and rosiglitazone. PCR analysis
showed that curcumin and rosiglitazone increased PPAR-γ
mRNA expression but decreased PDGFR-β mRNA expression in
TGF-β2-induced myofibroblasts in a dose-dependent manner. As
the control, curcumin and rosiglitazone had no significant effect
on the expression of FGFR1 mRNA (Figures 5A,B).
FIGURE 4 | Curcumin inhibits TGF-β2 induced α-SMA expression.
Mouse lung fibroblasts were pretreated with curcumin (50 µM) or rosiglitazone
(40 µM) for 2 h and then treated with TGF-β2 (10 ng/ml) for 24 h.
Immunocytochemical analysis for α-SMA (green, middle panel) was
performed, DAPI (blue, left panel) was used to visualize the nuclei, and
merged images were shown in right panel. Cur, curcumin; Rosi, rosiglitazone.
Bar: 20 µm.
Furthermore, Western blot analysis demonstrated that
curcumin and rosiglitazone significantly increased PPAR-γ
expression at protein level (Figure 5C), decreased PDGFR-β
expression at protein level (Figure 5D), but had no significant
effect on FGFR1 protein expression (Figure 5E).
DISCUSSION
Idiopathic pulmonary fibrosis affects approximately five million
people worldwide. IPF can lead to respiratory failure and
death due to deteriorating respiratory function, and is the
most common form of idiopathic interstitial pneumonias (IIPs),
among which IPF has the worst prognosis with median survival
of 3–5 years after diagnosis (Raghu et al., 2011; Olson and Swigris,
2012). The mechanism of IPF initiation and progression is poorly
understood, and the disease is refractory to current therapies.
Therefore, novel anti-fibrotic drugs are urgently needed for the
treatment of IPF.
Curcumin has shown anti-fibrotic effects, but the underlying
mechanisms remain poorly understood. In this study, we
demonstrated that curcumin and rosiglitazone inhibited TGF-β2
induced alterations of biological characteristics of mouse
lung fibroblasts, such as the suppression of proliferation
(Figure 1) and differentiation (Figure 2) of mouse lung
fibroblasts to myofibroblasts, the down-regulation of collagen
secretion (Figure 3) and α-SMA expression (Figure 4). Notably,
curcumin has stronger inhibitory effects on the proliferation
and differentiation of mouse lung fibroblasts than rosiglitazone.
Mechanistically, we found that the inhibitory effects of curcumin
are associated with the upregulation of PPAR-γ and the
downregulation of PDGFR-β (Figure 5).
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FIGURE 5 | Curcumin upregulates peroxisome proliferator-activated receptor gamma (PPAR-γ) and downregulates PDGFR-β during TGF-β2-induced
myofibroblast differentiation. (A) Mouse fibroblasts were treated for 24 h with TGF-β2 alone or together with 0–50 µM Cur. PPAR-γ, PDGFR-β, and FGFR1
mRNA levels were detected by PCR and normalized to β-actin mRNA. ∗P < 0.05, ANOVA. (B) Mouse fibroblasts were treated for 24 h with TGF-β2 alone or together
with 0–40 µM Rosi. PPAR-γ, PDGFR-β, and FGFR1 mRNA levels were detected by PCR and normalized to β-actin mRNA. ∗P < 0.05, ANOVA. (C) Western blot
analysis of PPAR-γ protein expression. ∗P < 0.05, ∗∗P < 0.05, #P < 0.05, ANOVA. (D) Western blot analysis of PDGFR-β protein expression. ∗P < 0.05, ∗∗P < 0.05,
ANOVA. (E) Western blot analysis of FGFR1 protein expression. ∗∗P < 0.05, ns P > 0.05, ANOVA. β-actin was loading control. Cur, Curcumin; Rosi, rosiglitazone.
Moreover, in this study we showed an antagonistic
relationship between PPAR-γ and PDGF. Interestingly, a recent
study reported that PPAR-γ inhibited hepatic stellate cells driven
angiogenesis via the suppression of PDGF-β receptor expression
and suggested that PPAR-γ could be a molecular target for
preventing vascular remolding in hepatic fibrosis (Zhang F.
et al., 2014). Therefore, we speculated that the activation of
PPAR-γ results in the interruption of PDGF signaling pathway,
leading to the inhibition of TGF-β2 driven differentiation of
mouse lung fibroblasts to myofibroblasts. Further studies are
needed to understand the interaction of PPAR-γ and PDGF in
the pathogenesis of IPF.
This study has several limitations. We only used in vitro
cell line and further in vivo studies in animal models
are needed to confirm the anti-fibrotic effects of curcumin.
While we linked anti-fibrotic effects of curcumin with the
regulation of PPAR-γ and PDGF expression by curcumin,
detailed underlying mechanisms remain elusive. There are
several pathways associated with fibrotic processes during IPF.
In this study, we only focused on TGF-β signaling pathway.
Further studies are necessary to determine whether curcumin
affects other signaling pathways that might be involved during
fibroblast proliferation, differentiation into myofibroblasts and
the expansion of ECM. Furthermore, TGF-β has been shown to
induce the apoptosis of fibroblasts. It is worthy investigating the
effects of curcumin on apoptotic pathways of fibroblasts.
CONCLUSION
This study reveals novel mechanism by which curcumin inhibits
TGF-β2 driven differentiation of mouse lung fibroblasts to
myofibroblasts. Curcumin and PPAR-γ could potentially be used
for effective treatment of IPF. Future in vivo studies are necessary
to confirm the promising potential of curcumin as therapeutics
for IPF.
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